Skip to main content
ADDvise Group B logo

ADDvise Group B — Investor Relations & Filings

Ticker · ADDV ISIN · SE0001306119 LEI · 549300C17TZXE1IEOA66 ST Wholesale and retail trade
Open in API
Filings indexed 399 across all filing types
Latest filing 2021-10-26 Board/Management Inform…
Country SE Sweden
Listing ST ADDV

About ADDvise Group B

https://www.addvisegroup.com/

ADDvise Group is an international life science company that provides comprehensive solutions, including products and services, to the healthcare and research sectors. The group operates through two primary business areas: Lab and Healthcare. The Lab division supplies laboratory equipment, furnishings, and consumables to public and private research facilities. The Healthcare division offers medical devices and equipment to various healthcare providers. ADDvise Group expands through the acquisition and development of high-quality companies, utilizing a decentralized ownership model that allows its subsidiaries to operate with autonomy while benefiting from corporate support.

Recent filings

Filing Released Lang Actions
ADDvise Group tillsätter ny CFO
Board/Management Information Classification · 100% confidence The document is a press release announcing the appointment of a new Chief Financial Officer (CFO) at ADDvise Group AB. It details the incoming executive's background and the effective date of the transition. This falls directly under the category of management changes.
2021-10-26 Swedish
ADDvise Group appoints new CFO
Board/Management Information Classification · 100% confidence The document is a press release announcing the appointment of a new Chief Financial Officer (CFO) and a change in the executive management team at ADDvise Group. This falls directly under the definition of Board/Management Information (MANG).
2021-10-26 English
ADDvise signs Letter of Intent to acquire Poly Pharmaceuticals, Inc.
M&A Activity Classification · 100% confidence The document is a press release announcing that ADDvise Group AB has signed a Letter of Intent to acquire Poly Pharmaceuticals, Inc. This falls under the category of M&A activity, as it details the acquisition terms, purchase price, and strategic intent.
2021-10-21 English
ADDvise tecknar avsiktsförklaring att förvärva Poly Pharmaceuticals, Inc.
M&A Activity Classification · 100% confidence The document is a press release announcing that ADDvise Group AB has signed a letter of intent to acquire Poly Pharmaceuticals, Inc. This is a clear announcement of a merger and acquisition (M&A) activity, detailing the purchase price, financial metrics of the target company, and the expected timeline for the transaction. It fits the definition of M&A Activity (TAR).
2021-10-21 Swedish
ADDvise Groups valberedning inför årsstämman 2022
Regulatory Filings Classification · 95% confidence The document is a press release announcing the composition of the Nomination Committee (valberedning) for the upcoming 2022 Annual General Meeting. It details the members of the committee, their appointing shareholders, and instructions for shareholders to submit nominations. This type of corporate governance announcement regarding the preparation for an AGM does not fit into the specific 'AGM-R' (which is for presentations/materials at the meeting) or 'PSI' (proxy solicitation) categories, and is best classified as a general regulatory announcement regarding corporate governance procedures.
2021-10-08 Swedish
ADDvise Group’s nomination committee for the Annual General Meeting 2022
Regulatory Filings Classification · 90% confidence The document is a press release announcing the composition of the nomination committee for the upcoming 2022 Annual General Meeting. It details the members of the committee and the process for shareholders to submit proposals. This type of announcement regarding board-related governance and meeting preparation falls under general regulatory announcements as it does not constitute the meeting materials themselves (AGM-R) or a proxy statement (PSI). Given the nature of the announcement regarding corporate governance structure, it is best classified as a Regulatory Filing (RNS).
2021-10-08 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.